Lower ghrelin concentrations are linked to gastrointestinal dysfunction, weight loss, and hyposmia, common symptoms of PD [313,314], while experimental ghrelin treatment improves GI motility and reduces dopaminergic neuron loss in animal models [309]. This evidence concerns the gene GHRL and Parkinson disease.